Logo
x

Search

Subscribe Now

Proposed Biosimilar

Samsung Bioepis Initiates P-III Clinical Trial of SB17 Proposed Biosimilar to Stelara (ustekinumab)

Samsung Bioepis Initiates P-III Clinical Trial of SB17 Proposed Biosimilar to Stelara (ustekinumab)

  • July 20, 2021
Bio-Thera Reports First Patient Dosing in P-III Study for BAT2206 Proposed Biosimilar of Stelara (ustekinumab)

Bio-Thera Reports First Patient Dosing in P-III Study for BAT2206 Proposed Biosimilar of Stelara (ustekinumab)

  • July 16, 2021
Gan Lee Presents P-I Results of Proposed Biosimilar Insulins Aspart- Lispro and Glargine at ADA 2021

Gan Lee Presents P-I Results of Proposed Biosimilar Insulins Aspart- Lispro and Glargine at ADA 2021

  • July 5, 2021
Alvotech Reaches PCD in its Switching Study for AVT02 (Proposed Biosimilar to Humira)

Alvotech Reaches PCD in its Switching Study for AVT02 (Proposed Biosimilar to Humira)

  • June 15, 2021
Alvotech Reports the US FDA and EMA's Acceptance of AVT02 Proposed Biosimilar to Humira (adalimumab)

Alvotech Reports the US FDA and EMA's Acceptance of AVT02 Proposed Biosimilar to Humira (adalimumab)

  • November 20, 2020
Alvotech Reports Results of AVT02 (a proposed biosimilar to adalimumab) in Two Clinical Studies for Autoimmune Diseases

Alvotech Reports Results of AVT02 (a proposed biosimilar to adalimumab) in Two Clinical Studies for Autoimmune Diseases

  • May 13, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.